The diagnosis and treatment of prostate cancer: a review

MS Litwin, HJ Tan - Jama, 2017 - jamanetwork.com
Importance Prostate cancer is the most common cancer diagnosis made in men with more
than 160 000 new cases each year in the United States. Although it often has an indolent …

Association of the placement of a perirectal hydrogel spacer with the clinical outcomes of men receiving radiotherapy for prostate cancer: a systematic review and …

LE Miller, JA Efstathiou, SK Bhattacharyya… - JAMA Network …, 2020 - jamanetwork.com
Importance Perirectal spacers are intended to lower the risk of rectal toxic effects associated
with prostate radiotherapy. A quantitative synthesis of typical clinical results with specific …

Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer

CN Catton, H Lukka, CS Gu, JM Martin… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Men with localized prostate cancer often are treated with external radiotherapy (RT)
over 8 to 9 weeks. Hypofractionated RT is given over a shorter time with larger doses per …

Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised …

L Incrocci, RC Wortel, WG Alemayehu… - The Lancet …, 2016 - thelancet.com
Background Studies have reported a low α/β ratio for prostate cancer, suggesting that
hypofractionation could enhance the biological tumour dose without increasing …

[HTML][HTML] Hypofractionated radiation therapy for localized prostate cancer: An ASTRO, ASCO, and AUA evidence-based guideline

SC Morgan, K Hoffman, DA Loblaw… - Journal of Clinical …, 2018 - ncbi.nlm.nih.gov
Background External beam radiation therapy (EBRT) is a standard definitive treatment
option for men with localized prostate cancer and confers long-term prostate cancer control …

Moderate hypofractionation in high-risk, organ-confined prostate cancer: final results of a phase III randomized trial

G Arcangeli, B Saracino, S Arcangeli… - Journal of Clinical …, 2017 - ascopubs.org
Purpose To report the final results on treatment outcomes of a randomized trial comparing
conventional and hypofractionated radiotherapy in high-risk, organ-confined prostate cancer …

Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

MK Thompson, P Poortmans, AJ Chalmers… - British journal of …, 2018 - nature.com
As we mark 150 years since the birth of Marie Curie, we reflect on the global advances
made in radiation oncology and the current status of radiation therapy (RT) research. Large …

Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey

D Rodin, B Tawk, O Mohamad, S Grover… - Radiotherapy and …, 2021 - Elsevier
Background and purpose Multiple large trials have established the non-inferiority of
hypofractionated radiotherapy compared to conventional fractionation. This study will …

[HTML][HTML] Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial

EM Monninkhof, JWL Van Loon, M van Vulpen… - Radiotherapy and …, 2018 - Elsevier
Purpose To compare toxicity rates in patients with localized prostate cancer treated with
standard fractionated external beam radiotherapy (EBRT) with or without an additional …

Texture analysis of 3D dose distributions for predictive modelling of toxicity rates in radiotherapy

L Rossi, R Bijman, W Schillemans, S Aluwini… - Radiotherapy and …, 2018 - Elsevier
Background and purpose To explore the use of texture analysis (TA) features of patients' 3D
dose distributions to improve prediction modelling of treatment complication rates in prostate …